Advisory Board

  • P.G. Baraldi

    Università di Ferrara, Ferrara, Italy

  • C.R. Bertozzi

    Stanford University, Stanford, California, USA

  • B.S.J. Blagg

    University of Kansas, Lawrence, Kansas, USA

  • M.-J. Blanco

    Sage Therapeutics, Cambridge, MA, USA

    Drug discovery and development, Medicinal Chemistry and Neuroscience

  • D.L. Boger

    The Scripps Research Institute, La Jolla, California, USA

  • M. Chu-Moyer

    Amgen Inc., Cambridge, Massachusetts, USA

    Small molecule drug discovery, Medicinal Chemistry, Synthetic Chemistry, ADME

  • P. Gmeiner

    Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

  • D. Hilvert

    Organic Chemistry Laboratory, Zurich, Switzerland

  • L.C. Hsieh-Wilson

    California Institute of Technology, Pasadena, California, USA

  • M. Ishibashi

    Chiba University, Chiba, Japan

    Natural products chemistry based on screening study targeting signaling pathways

  • W.L. Jorgensen

    Yale University, New Haven, Connecticut, USA

  • B.M. Kim

    Seoul National University (SNU), Seoul, The Republic of Korea

    HCV NS5A inhibition, quorum sensing inhibition and corticotropin releasing hormone receptor antagonism

  • M. Köhn

    EMBL Heidelberg, Heidelberg, Germany

    Bioorganic chemistry and Phosphatase chemical biology

  • K. Lackey

    Medical University of South Carolina (MUSC), Charleston, South Carolina, USA

    Drug Discovery, Medicinal Chemistry, Targeted Therapies

  • J. Lee

    Seoul National University (SNU), Seoul, The Republic of Korea

    Synthetic medicinal chemistry in drug discovery for Alzheimer’s; Pain and Anticancer drugs

  • C.E. Müller

    Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany

    G protein-coupled receptors, purine receptors, adenosine receptors, P2X receptors, P2Y receptors, adenine receptors, ectonucleotidases, assay development, radioligands, fluorescent ligands.

  • H.S. Overkleeft

    Universiteit Leiden, Leiden, Netherlands

  • P.G. Schultz

    The Scripps Research Institute, La Jolla, California, USA

  • P.H. Seeberger

    Max Planck Institute (MPI) of Colloids and Interfaces, Potsdam, Germany

    Carbohydrates, Synthesis, Glycobiology, Vaccines, Glycoproteins

  • O. Seitz

    Humboldt-Universität Berlin, Berlin, Germany

  • K. Shokat

    University of California at San Francisco (UCSF), San Francisco, California, USA

  • R.B. Silverman

    Northwestern University, Evanston, Illinois, USA

  • C.T. Supuran

    Università degli Studi di Firenze, Firenze, Italy

  • H. Takahashi

    Teikyo University, Tokyo, Japan

    axial chirality, asymmetric synthesis, conformational analysis, medicinal chemistry, carbohydrate chemistry

  • S. Walker

    Harvard University, Cambridge, Massachusetts, USA

  • S. Ward

    University of Sussex, Brighton, UK

    medicinal chemistry, ion channels, lead optimisation, neuroscience

  • P.A. Wender

    Stanford University, Stanford, California, USA

  • N. Winssinger

    Université de Genève, Geneva 4, Switzerland

    DNA-templated chemistry; DNA-encoded libraries (DEL); peptide nucleic acid; glycoconjugate synthesis.

  • C.-H. Wong

    The Scripps Research Institute, La Jolla, California, USA

  • W.-L. Zhu

    Chinese Academy of Sciences (CAS), Shanghai, China

    Molecular modeling and drug design, computational biology, medicinal chemistry, phytochemistry.